Advertisement

Sleep and Breathing

, Volume 20, Issue 4, pp 1169–1174 | Cite as

Comparison of American Academy of Sleep Medicine (AASM) versus Center for Medicare and Medicaid Services (CMS) polysomnography (PSG) scoring rules on AHI and eligibility for continuous positive airway pressure (CPAP) treatment

  • Arkady Korotinsky
  • Samson Z Assefa
  • Montserrat Diaz-Abad
  • Emerson M Wickwire
  • Steven M Scharf
Sleep Breathing Physiology and Disorders • Original Article

Abstract

Background

Obstructive sleep apnea (OSA) is an important clinical condition. Eligibility for treatment usually depends on disease severity, measured as the apnea-hypopnea index (AHI), equal to the sum of apneas plus hypopneas per hour of sleep. There is divergence on scoring rules for hypopneas between the recommendations of the American Academy of Sleep Medicine (AASM) and the Center for Medicare Services (CMS), the latter being more restrictive. Thus, patients could be eligible for treatment under AASM rules, but not under CMS rules.

Methods

Sleep laboratory records of 112 consecutive patients were reviewed (85 < 65, 27 ≥ 65 years old). AHI was calculated both by AASM and by CMS criteria. Information on demographics, and important comorbidities, was also reviewed.

Results

AHI was lower in younger patients using CMS criteria. However, differences in AHI using the two sets of criteria were not significantly different in the older patients. Incorporating all criteria for eligibility (severity, presence of certain comorbid conditions) for treatment, we found that fewer younger patients would be eligible using CMS criteria, but among the older patients, eligibility for treatment was the same whether AASM or CMS criteria were used.

Conclusions

Use of CMS criteria for scoring hypopneas results in lower estimates of OSA severity, with fewer younger patients eligible for treatment. However, among Medicare age patients, the rate of treatment eligibility was the same whether AASM or CMS scoring rules were used.

Keywords

Sleep apnea American Academy of Sleep Medicine Centers for Medicare Services Hypopnea criteria 

Notes

Compliance with ethical standards

Funding

No funding was received for this research.

Conflict of interest

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.

Ethical approval

All procedures performed in the studies were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments.

Informed consent

As the study was performed retrospectively from the clinical practice of the Sleep Disorders Center, and involved no manipulation by drug or device, and did not involve the collection of any identifiers, the Institutional Review Board ruled that informed consent was not necessary.

Disclosure statement

This was not an industry-supported study. The authors report no financial conflict of interest.

References

  1. 1.
    Young T, Evans L, Finn L, Palta M (1997) Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20:705–706CrossRefPubMedGoogle Scholar
  2. 2.
    Bradley TD, Floras JS (2003) Sleep apnea and heart failure part I: obstructive sleep apnea. Circulation 107:1671–1678CrossRefPubMedGoogle Scholar
  3. 3.
    Arzt M, Young T, Finn L, Skatrud JB, Bradley TD (2005) Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172:1447–1451CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053CrossRefPubMedGoogle Scholar
  5. 5.
    Otake K, Delaive K, Walld R, Manfreda J, Kryger MH (2002) Cardiovascular medication use in patients with undiagnosed obstructive sleep apnoea. Thorax 57:417–422CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Leung RS, Bradley TD (2001) Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147–2165CrossRefPubMedGoogle Scholar
  7. 7.
    Berry RB, Brooks R, Gamaldo CE, Harding SM, Lloyd RM, Marcus CL, Vaugh BV (2015) The AASM manual for the scoring of sleep and associated events. American Academy of Sleep Medicine. Online manual available at:http://www.aasmnet.org/scoringmanual/v2.2.0/html/index.html
  8. 8.
    Iber C, Ancoli-Israel S, Chesson AL Jr, Quan SF (2007) The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st edn. American Academy of Sleep Medicine, Westchester, ILGoogle Scholar
  9. 9.
    Centers for Medicare and Medicaid Services. (2001) Decision memo for continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) (CAG-00093 N). Available online at http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=19&fromdb=true.
  10. 10.
    Ho V, Crainiceanu CM, Punjabi NM, Redline S, Gottlieb DJ (2015) Calibration model for apnea-hypopnea indices: impact of alternative criteria for hypopneas. Sleep 38:1887–1892CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Greenberg H, Latkicova V, Scharf SM (2015) Obstructive sleep apnea: clinical features, evaluation, and principles of management. In: Kryger M. Principles and practice of sleep medicine. Elsevier, Philadelphia, PA – in pressGoogle Scholar
  12. 12.
    Williams A, Scharf SM (2015) Obstructive sleep apnea, cardiovascular disease, and inflammation—is nF-κB the key? Sleep Breath 11:69–76CrossRefGoogle Scholar
  13. 13.
    Martinez-Garcia MA, Campos-Rodriguez F, Solar-Cataluna JJ, Catalan-Serra P, Roman-Sanchez P, Montserrat JM (2012) Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Resp J 39:906–912CrossRefGoogle Scholar
  14. 14.
    Yang D, Liu Z, Yang H, Luo Q (2013) Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 17:33–38CrossRefPubMedGoogle Scholar
  15. 15.
    Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Diaz de Atauri MJ, Somoza M, Masa JF, Gonzalez M, Sacristan L, Barbe F, Duran-Cantolla AF, Marias E, Barreiro B, Mosteiro M, Celbrian JJ, de Pena M, Garcia-Rio F, Maimo A, Zapater J, Hernandez C, SanMarti NG, Montserrat JM (2013) for the Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension. The HIPARCO randomized clinical trial. JAMA 310:2407–2415CrossRefPubMedGoogle Scholar
  16. 16.
    Kaneko Y, Floras JS, Usui K, Plante J, Tkacova M, Kubo T, Ando S, Bradley TD (2003) Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. New Eng J Med 348:1233–1241CrossRefPubMedGoogle Scholar
  17. 17.
    Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS (2006) Practice parameters for the use of continuous and bilevel positive airway pressure to treat adult patients with sleep-related breathing disorders. Sleep 29:375–380CrossRefPubMedGoogle Scholar
  18. 18.
    Brown LE (2007) Mild sleep apnea syndrome should be treated. J Clin Sleep Med 3:259–262PubMedPubMedCentralGoogle Scholar
  19. 19.
    Littner MR (2007) Mild obstructive sleep apnea syndrome should not be treated. J Clin Sleep Med 3:263–264PubMedPubMedCentralGoogle Scholar
  20. 20.
    Marklund M, Carlberg B, Forsgren L, Olsson T, Stenlund H, Franklin KA (2015) Oral appliance therapy in patients with daytime sleepiness or mild to moderate sleep apnea; randomized clinical trial. JAMA Intern Med 175:1278–1285CrossRefPubMedGoogle Scholar
  21. 21.
    Ruehland WR, Rochford PD, Fergal J, O’Donoghue PRJ, Singh P, Thornton AT (2009) The new AASM criteria for scoring hypopneas: the impact on the apnea-hypopnea index. Sleep 32:150–157CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kuna ST, Benca R, Kushida CA, Walsh J, Younes M, Staley B, Hanlon A, Pack AI, Pien GW, Malhotra A (2014) Agreement in computer-assisted manual scoring of polysomnograms across sleep centers. Sleep 36:583–589Google Scholar
  23. 23.
    BaHammam AS, Obeidat A, Barataman K, Bahammam SA, Olaish AH, Sharif MM (2014) A comparison between AASM 2012 and 2007 definitions for detecting hypopnea. Sleep Breath 18:767–773CrossRefPubMedGoogle Scholar
  24. 24.
    Heinzer R, Vat S, Marques-Vidal P, Mari-Soler H, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Rubio JH (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Resp Med 3:310–318CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Arkady Korotinsky
    • 1
    • 2
  • Samson Z Assefa
    • 1
  • Montserrat Diaz-Abad
    • 1
  • Emerson M Wickwire
    • 1
  • Steven M Scharf
    • 1
  1. 1.Sleep Disorders Center, Division of Pulmonary and Critical Care MedicineUniversity of MarylandBaltimoreUSA
  2. 2.Department of Psychiatry, David Geffen UCLA School of MedicineWest Los Angeles Veterans Affairs Medical CenterLos AngelesUSA

Personalised recommendations